1-(4-methylbenzyl)piperidin-2-one

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 1-(4-methylbenzyl)piperidin-2-one
• 英文别名: 1-[(4-Methylphenyl)methyl]piperidin-2-one
• 化学式: C₁₃H₁₇NO
• 分子量: 203.284
• InChiKey: JUFPUYNBNHJQMW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  哌啶酮 、 (4-甲基苯基)甲醇 在 MnBr(CO)2[NH(CH₂CH₂P(Cy)2)2] 、 potassium tert-butylate 作用下， 以 甲苯 为溶剂， 反应 16.0h， 以35%的产率得到1-(4-methylbenzyl)piperidin-2-one
  参考文献：
  名称：

  Manganese-catalyzed direct C–C coupling of α-C–H bonds of amides and esters with alcohols via hydrogen autotransfer

  摘要：

  锰催化的酰胺和叔丁基醋酸酯的C-烷基化反应使用醇作为烷基化试剂。这种方法具有广泛的底物范围，通过氢自动转移策略提供良好产率的C(α)-烷基化酰胺。

  DOI：

  10.1039/c8dt05020a

文献信息

• Ni-Catalyzed α-Alkylation of Unactivated Amides and Esters with Alcohols by Hydrogen Auto-Transfer Strategy
  作者：Siba P. Midya、Jagannath Rana、Jayaraman Pitchaimani、Avanashiappan Nandakumar、Vedichi Madhu、Ekambaram Balaraman

  DOI：10.1002/cssc.201801443

  日期：2018.11.23

  A transition‐metal‐catalyzed borrowing hydrogen/hydrogen auto‐transfer strategy allows the utilization of feedstock alcohols as an alkylating partner, which avoids the formation of stoichiometric salt waste and enables a direct and benign approach for the construction of C‐N and C−C bonds. In this study, a nickel‐catalyzed α‐alkylation of unactivated amides and ester (tert‐butyl acetate) is carried

  过渡金属催化借用的氢/氢自动转移策略允许将原料醇用作烷基化伙伴，从而避免了化学计量盐废物的形成，并为C-N和C-的构建提供了直接而良性的方法C键。在这项研究中，在温和条件下使用伯醇对镍进行了未活化的酰胺和酯（乙酸叔丁酯）的镍催化的α-烷基化反应。这种C-C键形成反应由一种新的分子定义的镍（II）NNN-钳形配合物（0.1-1 mol％）催化，并通过氢自动转移进行，从而释放出水作为唯一的副产物。此外，还证明了在Ni催化条件下环状酰胺的N烷基化作用。
• Novel carbapenem compound
  申请人：Sunagawa Makoto

  公开号：US20090029964A1

  公开（公告）日：2009-01-29

  An orally administrable antibacterial agent which contains as an active ingredient a carbapenem compound represented by the formula [1] below, wherein R 0 represents hydrogen atom or the like; R 1 represents C 1 -C 3 alkyl substituted by hydroxyl group or the like; R represents hydrogen atom or a group which regenerates a carboxyl group by hydrolysis in a living body; L represents a single bond, methylene, —OCH 2 (CO)— or the like; and Het represents a group represented by the following formula [2], wherein m and n independently represent 0 or 1; A and B independently represent methylene, carbonyl or the like; Y represents methylene, ethylene, oxygen atom, —OCH 2 —, —NR a CH 2 — (wherein R a represents hydrogen atom, optionally substituted C 1 -C 4 alkyl group or the like) or the like.

  一种口服抗菌剂，其活性成分为由下式[1]表示的碳青霉烯化合物，其中R0表示氢原子或类似物；R1表示C1-C3烷基，该烷基被羟基或类似物取代；R表示氢原子或通过水解在活体内再生羧基的基团；L表示单键，亚甲基，—OCH2（CO）—或类似物；Het表示由下式[2]表示的基团，其中m和n独立地表示0或1；A和B独立地表示亚甲基，羰基或类似物；Y表示亚甲基，乙烯基，氧原子，—OCH2—，—NRaCH2—（其中Ra表示氢原子，可选取代的C1-C4烷基或类似物）或类似物。
• Substituted Quinolines and Their Use As Medicaments
  申请人：Boehringer Ingelheim International GmbH

  公开号：US20150065489A1

  公开（公告）日：2015-03-05

  Disclosed are substituted quinolines of formula 1 wherein R 1 and R 2 are defined herein, the processing of making and using the same.

  公开了式1中R1和R2定义如下的取代喹啉，以及制备和使用它们的方法。
• Lincomycin Derivatives and Antimicrobial Agents Comprising the Same as Active Ingredient
  申请人：Umemura Eijirou

  公开号：US20090156512A1

  公开（公告）日：2009-06-18

  This invention provides compounds of formula (I) or its pharmacologically acceptable salt or solvate, wherein A represents aryl or a monocyclic or bicyclic heterocyclic group, R 1 represents a halide, nitro, substituted C 1-6 alkyl, optionally substituted amino, C 1-6 alkyloxycarbonyl, optionally substituted aryl, a heterocyclic group, or heterocyclic carbonyl, R 2 represents a hydrogen atom or C 1-6 alkyl, R 3 represents C 1-6 alkyl, all of R 4 , R 5 , and R 6 represent a hydrogen atom, R 7 represents C 1-6 alkyl, m is 1 or 2, and n is 1. The compounds are novel lincomycin derivatives having a potent activity against resistant pneumococci. The compounds can be used as an antimicrobial agent and are useful for preventing or treating bacterial infectious diseases.

  本发明提供了式（I）的化合物或其药理学上可接受的盐或溶剂，其中A代表芳基或单环或双环杂环基，R1代表卤素、硝基、取代的C1-6烷基、可选取代的氨基、C1-6烷氧羰基、可选取代的芳基、杂环基或杂环羰基，R2代表氢原子或C1-6烷基，R3代表C1-6烷基，R4、R5和R6均代表氢原子，R7代表C1-6烷基，m为1或2，n为1。这些化合物是新型的林可霉素衍生物，对耐药性肺炎球菌具有强大的活性。这些化合物可以用作抗微生物剂，并且对于预防或治疗细菌感染性疾病是有用的。
• NOVEL CARBAPENEM COMPOUND
  申请人：Dainippon Sumitomo Pharma Co., Ltd.

  公开号：EP1864985A1

  公开（公告）日：2007-12-12

  An orally administrable antibacterial agent which contains as an active ingredient a carbapenem compound represented by the formula [1] below, wherein R0 represents hydrogen atom or the like; R1 represents C1-C3 alkyl substituted by hydroxyl group or the like; R represents hydrogen atom or a group which regenerates a carboxyl group by hydrolysis in a living body; L represents a single bond, methylene, -OCH2(CO)- or the like; and Het represents a group represented by the following formula [2], wherein m and n independently represent 0 or 1; A and B independently represent methylene, carbonyl or the like; Y represents methylene, ethylene, oxygen atom, -OCH2-, -NRaCH2- (wherein Ra represents hydrogen atom, optionally substituted C1-C4 alkyl group or the like) or the like.

  一种可口服的抗菌剂，其活性成分是由下式[1]代表的碳青霉烯类化合物、 其中 R0 代表氢原子或类似物；R1 代表被羟基或类似物取代的 C1-C3 烷基；R 代表氢原子或在活体内通过水解再生羧基的基团；L 代表单键、亚甲基、-OCH2(CO)- 或类似物；Het 代表下式[2]所代表的基团、 其中 m 和 n 独立地代表 0 或 1；A 和 B 独立地代表亚甲基、羰基或类似物；Y 代表亚甲基、乙烯、氧原子、-OCH2-、-NRaCH2-（其中 Ra 代表氢原子、任选取代的 C1-C4 烷基或类似物）或类似物。